HYSI, ALBANA
 Distribuzione geografica
Continente #
EU - Europa 66
NA - Nord America 41
AS - Asia 39
AF - Africa 2
OC - Oceania 1
Totale 149
Nazione #
US - Stati Uniti d'America 38
IT - Italia 28
CN - Cina 10
FR - Francia 10
IE - Irlanda 8
IN - India 8
VN - Vietnam 8
DE - Germania 7
KR - Corea 4
SE - Svezia 4
CA - Canada 3
LB - Libano 3
DK - Danimarca 2
ES - Italia 2
GB - Regno Unito 2
JO - Giordania 2
KE - Kenya 2
AE - Emirati Arabi Uniti 1
CZ - Repubblica Ceca 1
GR - Grecia 1
ID - Indonesia 1
IL - Israele 1
NL - Olanda 1
NZ - Nuova Zelanda 1
TR - Turchia 1
Totale 149
Città #
Dong Ket 8
Ashburn 6
Boardman 5
Dublin 5
Stockholm 4
Beijing 3
Camerino 3
Dundalk 3
Houston 3
Montréal 3
Wuhan 3
Ann Arbor 2
Chennai 2
Chieti 2
Cincinnati 2
Davis 2
Falls Church 2
Leawood 2
Nairobi 2
Nowon-gu 2
Pesaro 2
Abu Dhabi 1
Auckland 1
Baratili San Pietro 1
Barcelona 1
Bareilly 1
Bengaluru 1
Berlin 1
Biella 1
Braunschweig 1
Council Bluffs 1
Dearborn 1
Fermo 1
Glasgow 1
Halle 1
Hamburg 1
Huntington 1
Jakarta 1
Leipzig 1
Los Angeles 1
Lucknow 1
Motherwell 1
Mumbai 1
Norwalk 1
Nuremberg 1
Olomouc 1
Paris 1
Redmond 1
Rome 1
San Benedetto Del Tronto 1
San Benedetto del Tronto 1
Sanayi 1
Tel Aviv 1
Thessaloníki 1
Tolentino 1
Trento 1
Whittier 1
Totale 102
Nome #
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells, file e4233f16-3e71-2860-e053-6605fe0a460a 77
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib, file e4233f16-3e16-2860-e053-6605fe0a460a 49
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor, file e4233f16-4985-2860-e053-6605fe0a460a 19
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis, file e4233f16-4136-2860-e053-6605fe0a460a 10
Totale 155
Categoria #
all - tutte 537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 2 2
2019/202027 1 2 1 6 1 0 1 1 3 5 4 2
2020/202136 2 1 10 2 3 0 3 2 2 2 0 9
2021/20229 0 0 1 0 2 0 0 2 0 0 1 3
2022/202347 7 0 1 3 2 5 7 0 3 1 13 5
2023/202431 3 1 2 3 0 5 8 1 4 4 0 0
Totale 155